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Summary
Plasma aminograms of infants receiving total
parenteral nutrition as part of the treatment for
necrotizing enterocolitis were studied. Their ages
varied from 2 to 60 days and their mean birth mass
was 1621 g (range 760-2550 g). The intravenous
administration of amino acids produced changes in
plasma amino acid levels corresponding to the
concentration of individual amino acid levels in the
solution employed: higher levels of amino acids in
the infusate produced increased plasma levels,
whereas low plasma levels were obtained for amino
acids not present or present in small amounts
according to the solution used. The infants did not
appear to suffer in any way, but the long-term
effects still have to be evaluated. Pending further
knowledge in this regard it is suggested that plasma
amino acid levels should be maintained as near to
normal values as possible. This could probably be
achieved by the use of amino acid solutions
specially formulated according to the amino acid
profile of breast milk or the plasma amino acid
profile of normal infants.
S. Atr. med. J .. 59,946 (1981).
Neonatal necrotlzmg enterocolitis (NEC) carries a high
mortality rate. Fatalities are usually associated with intestinal
perforation and subsequent peritonitis. Oral feeds are
accordingly contraindicated, and total parenteral nutrition
(TPN) is an established practiceYs Amino acids are integral
constituents of the mixtures administered intravenously during
TPN, preferably using the laevorotator crystalline form. 29
Amino acid preparations which may disturb the normal
plasma amino acid profile are potentially harmful to infants,
since brain development may be impaired by a deficiency or an
excess of plasma amino acids. 5,14 The brain is very sensitive
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during the major growth spurt, which in humans begins about
the middle of gestation and ends between the second and third
year of life.
Synthamin (SABAX), the crystalline amino acid solution
which was commercially available to us at the time of this study
for use in parenteral nutrition, is not balanced according.ro the
needs of infants regarding its amino acid composition, and does
not contain all the amino acids essential for normal growth and
development (see Discussion).3,4 Accordingly, it was decided to
study plasma amino acid levels in infants with NEC on a TPN
regimen, of which Synthamin was an integral part.
Patients and methods
Plasma amino acid concentrations were measured in 64 infants
receiving TPN as part or'the treatment for NEC, the clinical
diagnosis having been radiologically confirmed. The clinical
details of these patients will be reported in a separate article.
The ages of the patients varied from 2 to 60 days, and their
birth weights from 760 to 2550 g (mean 1621 g). They were
treated in isolation for a minimum period of 21 days, during
which time oral feeds were withheld. Synthamin, mineral salts,
electrolytes, dextrose and vitamins were prepared aseptically
under laminar flow and administered intravenously at a rate of
160 mVkg/24 h. The amino acid concentration of the mixture
was gradually increased. to provide 2,4 g proteins,ll per kg body
mass per day from the 4th day onwards. A fat solution (10%
Intralipid) was infused daily at a rate of up to 40 ml/kg,
depending on clearance from the plaslIla.
Tobramycin was the antibiotic used routinely, a dosage of2,5
mg/kg/8 h being administered for 14 days. Blood or plasma, 20
ml/kg body mass, was infused weekly. Vitamins were
administered as part of the treatment regimen, details of which,
as well as details of clinical and biochemical observations of the
patients, will be published in a separate article.
Since it was considered unwarranted and potentially harmful
to draw repeated blood specimens from small, very ill.infants,
venous blood samples (approximately 0,5 ml) for plasma
aminograms were obtainep as follows: before commencing TPN
(7 infants); after 4 days ofTPN (8 infaim); after 6-8 days ofTPN
(16 infants); after 14 days of TPN (9 infants); after 21 days of
TPN (18 infants); and after 4 days on oral milk feeds (6 infants).
Plasma aminograms were done on the following healthy
infants (controls) after having obtained informed consent from
the mothers: 29 premature infants of 1 day old, with a mean birth
mass of 1227 g (685-2920 g); 5 premature infants of 5-14 days
old, with a mean birth mass of I 227 g (685-2920 g): and 6 full-
term infants of 1-6 days old, with a mean birth mass of 2737 g
(2020-3948 g).
Amino acid analysis.)l Blood specimens were centrifuged.
Plasma was deproteinized with sulphosalicylic acid containing
an internal standard, and 100 }.d ofsupematant fluid was used for
the measurement of amino acid concentrations. Specimens not
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analysed immediarely were stored ar O°e. All measuremenrs
were performed in duplicare wirh a Beckman Model 119 El
amino acid analyser (Beckman Insrrumenrs Inc., Spinco
Division, Palo Alto, Calif.). Chromatograms were continuously
monitored and inregrared on a Hewlerr-Packard computer
integraring sysrem (HP 3352 B). This sysrem employs an inrernal
srandard merhod and gives a recovery figure of 100 ± 2% for all
amino acids.
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Fig. 1. Histogram of mean plasma amino acid concentrations determined
in healthy premature and lull-term infants compared with plasma
concentrations in infants with NEe.
Plasma amino acid concentrarions varied considerably in rhe
individual parienrs, but rhere was remarkable similariry in rhe
mean amino acid levels. Table I summarizes the mean plasma
amino acid levels of healthy premature infanrs, full-rerm infanrs
and NEC patienrs. Aminograms of TEC parienrs were obrained
before and during rreatment as well as afrer complerion of rhe
therapy and the commencemenr of milk-feeding.
The inrravenous adminisrrarion of amino acids produced a
marRed increase in rhe plasma levels of some of the constituenr
acids (Table I, Fig. I). Plasma levels of alanine and glycine
increased fourfold wirhin days of commencing intravenous
infusion. This increase was followed by a gradual decline, normal
plasma concentrarions being reached only on day 25, i.e. 4 days
after the intravenous administrarion of amino acids was
disconrinued and oral milk feeds \vere started.
Plasma levels of hisridine, argmme and cystine followed a
similar pattern, an inirial elevation and a gradual decline for
arginine and hisridine. The amino acid solution did nor conrain
cysrine, which may explain rhe low plasma levels of rhe larrer.
Plasma levels of raurine remained srable during the period of
treatment, although lower than the levels for healrhy infanrs.
Taurine was nor provided in rhe inrravenous amino acid
prepararion administered. Methionine showed a marked
increase in plasma concenrrarion, while rhere was a gradual
decline in tyrosine levels. Synrhamin conrains only a small
amounr of ryrosine.
A similar variarion in the plasma levels of the orher amino
acids was observed, normal values being established only afrer
oral feeds had been instituted. The changes in plasma amino acid
levels corresponded to rhe concenrrarion of individual amino
acids in the solution employed. The amino acid profile of rhe
plasma before commencement of rherapy correlated well wirh
thar ofbreasr milk. Synrhamin adminisrrarion produced elevared
levels of those amino acids presenr in higher concenrrarion in rhe
solution (Fig. 2).
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Discussion
Fig. 2. Histogram of amino acid profiles of breast milk, Synthamin and
plasma of infants.
It seems therefore that plasma amino acid levels in neonates
are not affected by age or mass (Table I). However, the plasma
levels of individual amino acids are affected by the intravenous
administration of an amino acid solution, and return to normal
when the amino acid infusion is discontinued and oral feeds are
given. It is evident that the plasma amino acid levels during
intravenous amino acid infusion vary according to the amino acid
pattern of the infusate.
Conclusion
The individual aminograms are available from: Dr J. C. Thorn,
Dept of Paediatrics, University of Stellenbosch, PO Box 63,
Tygerberg, 7505 RSA.
This study highlights the importance of the intravenous infusion
in infants of an amino acid solution which supplies adequate
amounts of amino acids in proportions suitable to their special
needs. It also stresses the importance of measuring amino ~cid
levels before, during and after TPN in order to monitor the
plasma concentrations.
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and failure to provide adequate amounts of taurine in the diet or
infusate may affect brain and retinal development adversely.
Preterm infants are not able to convert methionine,
phenylalanine and glycine adequately to gstine,tyrosine and
serine owing to poor enzyme function. 13.1~,17,23.26 Other amino
acids are similarly affected. This results in inadequate
availability of some amino acids and accumulation of others,
which may in turn result in severe neurological damage when
toxic levels are reached. Adequate amounts of amino acids
should be given to infants in the proportions necessary for rapid
growth, ensuring that none of these is present in excessive
quantities, lest metabolic overloads occur. The amino acid may
concentrate in the blood to levels as high as those observed in
certain inborn ertors of amino acid metabolism. There is
evidence that premature infants who experience this sort of
imbalance in amino acid levels may suffer intellectual or
neurological impairment. In more than 50% of cases <:f.inborn
errors of metabolism, brain damage has been associated with
elevated plasma amino acid levels.s
The administration of poorly balanced amino acid solutions
will cause an overload of some metabolic pathways, with
consequent elevation of plasma levels ofsome amino acids, while
inadequate levels of essential amino acids in the solution
administered will result in low plasma levels of these acids. Both
situations pose a threat to the recipient infant.5 ,9,14
The abnormal amino acid profile found in this study after
intravenous infusion of the amino acid solution, Synthamin, is a
matter of concern. The amino acid composition of Synthamin is
not formulated according to the amino acid profile ofbreast milk
protein, and contains large amounts of alanine, glycine,
phenylalanine, methionine and arginine but is deficient in
taurine, cystine, tyrosine and serine. It is known that the plasma
amino acid concentrations reflect the profile of the infusate
during administration.8,16,21 It is therefore certain that the
administration of Synthamin resulted in the abnormal plasma
amino acid profile found in this study (Fig. 2).
How important is this disturbed plasma amino acid profile to
the well-being of the infant? Long-term effects still have to be
evaluated, but infants on the treatment regime-n did not appear to
suffer in any way. In the light of the present knowledge ofamino
acid metabolism in infants, however, it seems prudent to
maintain the plasma amino acid concentration ofinfants on TPN
as near to normal values as possible.
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Protein synthesis depends on the availability of amino acids in
the plasma. The supply of protein - amino acids - to the body
should be adequate to.maintain a positive nitrogen balance. In
the event of failure to ingest protein, it should be administered
intravenously, preferably in the form of L-crystalline amino
acids. 29
Blood, plasma and albumin are poor substitutes for an amino
acid infusion, since they provide the amino acids for endogenous
protein synthesis only after variable periods oftime: plasma after
10 days, red blood cells after 90-120 days, and albumin only after
2-3 weeksY
Amino acid preparations for intravenous infusion should
contain the 20 amino acids considered necessary for the synthesis
of human protein. IS The composition of the amino acid solution
employed in the treatment regimen should also be adapted to the
requirements of the patient according to age and specific need,
e.g. 40% of an infant's protein intake should be in the form of
essential amino acids. The relevant figure for adults is 19%.31 The
G P · R' 34FAO/WHO Expert roup on rotem eqUlrements .
concluded that the ideal amino acid pattern should be similar to
that of human milk protein or egg protein.
At cell-level, all amino acids necessary for normal growth and
development are essential. The non-essential amino acids,
however, can be synthesized adequately by the body and these
should be adequately provided in the infusate. Amino acid
symhesis is impaired in the neonate because ofthe immaturity of
enzyme function. Accordingly, besides the amino acids essential
for adults, i.e. leucine, isoleucine, lysine, methionine,
phenylalanine, threonine, tryptophan and valine, the neonate
must also be provided with histidine, cystine, tyrosine, arginine,
taurine, proline and alanine. The infant is incapable of
synthesizing these adequately.6,7, 10,13, 17,19,20,22,24,26
Deficiencies in any of these amino acids may affect the infant
seriously, causing quantitative deficits rather than actual
destruction of nerve tissue. For example, taurii'Ie is regarded as
essential for the normal development of brain and retina,2,25,27
